Indaptus Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a INDP research report →
About the company
Indaptus Therapeutics, Inc. is a biotechnology company operating in the pre-clinical phase, dedicated to developing a range of immunotherapeutic products for the treatment of both cancer and viral infections. The firm's lead investigational compound, Decoy20, is currently progressing through Phase I clinical trials.
- CEO
- Junyi Dai
- IPO
- 2015
- Employees
- 7
- HQ
- New York City, NY, US
Price Chart
- Market Cap
- $5.31M
- P/E
- -0.48
- P/S
- 0.00
- P/B
- 5.26
- EV/EBITDA
- -0.20
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -1028.81%
- ROIC
- -1396.04%
- Revenue
- $0 · 0.00%
- Net Income
- $-20,848,916 · -38.79%
- EPS
- $-21.58 · -1240.37%
- Op Income
- $-19,833,513
- FCF YoY
- -20.29%
- 52W High
- $13.40
- 52W Low
- $0.92
- 50D MA
- $2.58
- 200D MA
- $2.53
- Beta
- 1.27
- Avg Volume
- 1.02M
Get TickerSpark's AI analysis on INDP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 8, 26 | Lu Qinglai | other | 0 |
| Mar 23, 26 | Yao Yun | other | 0 |
| Mar 23, 26 | SINO LION VENTURES Ltd | other | 0 |
| Mar 23, 26 | Dai Junyi | other | 0 |
| Mar 23, 26 | Lazar David E. | sell | 196,800 |
| Mar 23, 26 | Lazar David E. | sell | 700,000 |
| Feb 26, 26 | Jabbour Jerome D | other | 25,000 |
| Feb 26, 26 | Jabbour Jerome D | other | 0 |
| Feb 26, 26 | McMurdo Matthew Charles | other | 0 |
| Feb 11, 26 | Meckler Jeffrey A | other | 12,136 |
Our INDP coverage
Recent articles, reports, and earnings notes.
No research on INDP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate INDP report →Similar companies
Peers in the same neighborhood.